Royal Bank of Canada’s SteadyMed Ltd STDY Stock Holding History

Royal Bank of Canada’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-800	Closed	-$2K	–	6968
2016 Q4	$2K	Hold	800	–	–	﹤0.01%	6511
2016 Q3	$3K	Hold	800	–	–	﹤0.01%	6132
2016 Q2	$3K	Hold	800	–	–	﹤0.01%	6100
2016 Q1	$2K	Buy	800 +500	+167%	+$1.24K	﹤0.01%	6169
2015 Q4	$1K	Sell	300 -1,000	-77%	-$3.01K	﹤0.01%	6549
2015 Q3	$5K	Sell	1,300 -7,000	-84%	-$31.9K	﹤0.01%	6187
2015 Q2	$44K	Buy	8,300 +5,786	+230%	+$46.7K	﹤0.01%	5293
2015 Q1	$21K	Buy	+2,514	New	+$21.5K	﹤0.01%	5345

Other funds holding STDY

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada's STDY Position: Q1 2017 in Review

Royal Bank of Canada sold out of SteadyMed Ltd (STDY) in Q1 2017, closing a stake of 800 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in STDY in Q1 2015 and held it in 8 quarters. The position peaked at $44K in Q2 2015. 17 funds tracked by Wall St. Rank hold STDY as of Q1 2017.

Royal Bank of Canada reported no remaining SteadyMed Ltd position as of Q1 2017 after selling out during the quarter.
Royal Bank of Canada sold 800 SteadyMed Ltd shares in Q1 2017, an estimated $2K.
Royal Bank of Canada first reported a position in SteadyMed Ltd in Q1 2015 and held it in 8 quarters.
Royal Bank of Canada's SteadyMed Ltd position peaked at $44K in Q2 2015.
17 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q1 2017.

Based on Royal Bank of Canada's 13F filing for Q1 2017, filed 15 May 2017.